Health

Petra Wilder-Smith, Director of Dentistry, Beckman Laser Institute & Medical Clinic. Professor, School of Medicine

An anticancer camera?

Dr. Petra Wilder-Smith’s screening device takes aim at oral lesions

Bernadette Boden-Albala walking on a path with five females.

UC Irvine’s Public Health Program to transition to School of Population and Public Health

The first in O.C., it will advance innovative training and cutting-edge research

Dana Mukamel

UC Irvine-led study reveals relationship between nursing home staffing types and quality of care

Optimal health outcomes require insight into relationship between disciplines, residents’ needs

Alexandre Chan, UCI chair and professor of clinical pharmacy practice

UC Irvine’s electronic patient-reported outcome tool reduces cancer care disparities

Multilanguage application helps manage symptoms of diverse racial, ethnic patients

Smiling woman standing in front of plants. says Jung-Ah Lee, professor and associate dean for diversity, equity, inclusion and belonging at UC Irvine’s Sue & Bill Gross School of Nursing.

UC Irvine nursing professor is inducted into Sigma Theta Tau international hall of fame

Jung-Ah Lee’s geriatric care research aims to improve family caregivers’ quality of life

Alison Holman Professor, Robert Wood Johnson Foundation Nurse Faculty Scholar, UC Irvine Sue & Bill Gross School of Nursing

Avoiding media-fueled psychological distress

UC Irvine-led experts call for public education about risks of exposure to graphic images, such as those from Israel-Hamas war

UC Irvine School of Medicine Dean Michael Stamos.

Advancing regenerative medicine therapies

Discoveries in the new GMP facility will expand novel gene and cell treatment options for patients

Group of people

CNCM is awarded $1.4 million NIH grant for Alzheimer’s disease research training

Funds will support projects with significant clinical translational potential

Photo: CD8+ T cells (yellow) activated by PD-1 blockade also interact with T regulatory cells (teal and red), which subsequently dampen the immune response against the melanoma tumor cells (blue)

‘Cutting the cable’ between CD8+ T and T regulatory cells enhances checkpoint immunotherapy

Discovery by UC Irvine-led team may offer new strategy for improving melanoma treatment

Chad Lefteris, CEO of UCI Health

Driving UCI Health’s Expansion

Q&A with Chad Lefteris, CEO of UCI Health